These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34174820)

  • 1. Immunization with Pneumocystis carinii A12
    Tong T; Wang Z; Xu Y; Shen J
    BMC Immunol; 2021 Jun; 22(1):40. PubMed ID: 34174820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.
    Tesini BL; Wright TW; Malone JE; Haidaris CG; Harber M; Sant AJ; Nayak JL; Gigliotti F
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28031260
    [No Abstract]   [Full Text] [Related]  

  • 3. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen.
    Wells J; Haidaris CG; Wright TW; Gigliotti F
    Infect Immun; 2006 Apr; 74(4):2446-8. PubMed ID: 16552076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic p55 tandem DNA vaccine against Pneumocystis carinii in rats.
    Fan H; Guo JY; Ma SL; Zhang N; An CL
    Microbiol Immunol; 2016 Jun; 60(6):397-406. PubMed ID: 27185490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization.
    Smulian AG; Sullivan DW; Theus SA
    Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats.
    Feng Y; Guo S; Jiang T; Han X; Liu P; Wu T; Luo Y
    Can J Microbiol; 2011 May; 57(5):375-81. PubMed ID: 21529125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.
    Ruan S; Cai Y; Ramsay AJ; Welsh DA; Norris K; Shellito JE
    Vaccine; 2017 Jan; 35(4):672-679. PubMed ID: 28012778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia.
    Gigliotti F; Wiley JA; Harmsen AG
    Infect Immun; 1998 Jul; 66(7):3179-82. PubMed ID: 9632583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-Induced Immunogenicity and Protection Against Pneumocystis Pneumonia in a Nonhuman Primate Model of HIV and Pneumocystis Coinfection.
    Kling HM; Norris KA
    J Infect Dis; 2016 May; 213(10):1586-95. PubMed ID: 26823337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.
    Pascale JM; Shaw MM; Durant PJ; Amador AA; Bartlett MS; Smith JW; Gregory RL; McLaughlin GL
    Infect Immun; 1999 Feb; 67(2):805-9. PubMed ID: 9916094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with
    Cobos Jiménez V; Rabacal W; Rayens E; Norris KA
    Hum Vaccin Immunother; 2019; 15(9):2075-2080. PubMed ID: 31348719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant major surface glycoprotein of Pneumocystis carinii elicits a specific immune response but is not protective in immunosuppressed rats.
    Lasbury ME; Angus CW; Klivington D; Durant PJ; Bartlett MS; Smith JW; Lee CH
    J Eukaryot Microbiol; 1999; 46(5):136S-137S. PubMed ID: 10519289
    [No Abstract]   [Full Text] [Related]  

  • 13. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.
    Empey KM; Hollifield M; Schuer K; Gigliotti F; Garvy BA
    Infect Immun; 2004 Nov; 72(11):6211-20. PubMed ID: 15501746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia.
    Lundgren B; Lundgren JD; Nielsen T; Mathiesen L; Nielsen JO; Kovacs JA
    J Infect Dis; 1992 Jun; 165(6):1151-5. PubMed ID: 1583338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.
    Samuelson DR; de la Rua NM; Charles TP; Ruan S; Taylor CM; Blanchard EE; Luo M; Ramsay AJ; Shellito JE; Welsh DA
    J Immunol; 2016 Mar; 196(6):2655-65. PubMed ID: 26864029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.
    Bishop LR; Helman D; Kovacs JA
    BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection.
    Fisher DJ; Gigliotti F; Zauderer M; Harmsen AG
    Infect Immun; 1991 Oct; 59(10):3372-6. PubMed ID: 1894351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen.
    Theus SA; Sullivan DW; Walzer PD; Smulian AG
    Infect Immun; 1994 Aug; 62(8):3479-84. PubMed ID: 8039919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming Hurdles to Development of a Vaccine against Pneumocystis jirovecii.
    Garvy BA
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28115507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacies of chitosan against Pneumocystis pneumonia of immunosuppressed rat.
    Liu AB; Pu Y; Zheng YQ; Cai H; Ye B
    Parasite Immunol; 2014 Jul; 36(7):292-302. PubMed ID: 24702055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.